<VariationArchive VariationID="1032776" VariationName="NM_001854.4(COL11A1):c.3816+2dup" VariationType="Duplication" Accession="VCV001032776" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1019098" VariationID="1032776">
      <GeneList>
        <Gene Symbol="COL11A1" FullName="collagen type XI alpha 1 chain" GeneID="1301" HGNC_ID="HGNC:2186" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="102876473" stop="103108522" display_start="102876473" display_stop="103108522" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="103342022" stop="103574051" display_start="103342022" display_stop="103574051" Strand="-" />
          </Location>
          <OMIM>120280</OMIM>
          <Haploinsufficiency last_evaluated="2011-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL11A1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2011-10-19" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL11A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001854.4(COL11A1):c.3816+2dup</Name>
      <CanonicalSPDI>NC_000001.11:102915628:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="102915628" stop="102915629" display_start="102915628" display_stop="102915629" variantLength="1" positionVCF="102915628" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="103381184" stop="103381185" display_start="103381184" display_stop="103381185" variantLength="1" positionVCF="103381184" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.103381185dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.103381185dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.102915629dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.102915629dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008033.2" sequenceAccession="NG_008033" sequenceVersion="2" change="g.197868dup">
            <Expression>NG_008033.2:g.197868dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190709.2" sequenceAccession="NM_001190709" sequenceVersion="2" change="c.3699+2dup">
            <Expression>NM_001190709.2:c.3699+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080629.3" sequenceAccession="NM_080629" sequenceVersion="3" change="c.3852+2dup">
            <Expression>NM_080629.3:c.3852+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080630.4" sequenceAccession="NM_080630" sequenceVersion="4" change="c.3468+2dup">
            <Expression>NM_080630.4:c.3468+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001854.4" sequenceAccession="NM_001854" sequenceVersion="4" change="c.3816+2dup" MANESelect="true">
            <Expression>NM_001854.4:c.3816+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="COL11A1_000107" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="120280.0006" DB="OMIM" />
        <XRef Type="rs" ID="1469787406" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001854.4(COL11A1):c.3816+2dup AND Fibrochondrogenesis 1" Accession="RCV001334963" Version="1">
        <ClassifiedConditionList TraitSetID="6448">
          <ClassifiedCondition DB="MedGen" ID="C3278138">Fibrochondrogenesis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001854.4(COL11A1):c.3816+2dup AND not provided" Accession="RCV001859329" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-27" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001854.4(COL11A1):c.3816+2dup AND Marshall syndrome" Accession="RCV002260151" Version="1">
        <ClassifiedConditionList TraitSetID="5653">
          <ClassifiedCondition DB="MedGen" ID="C0265235">Marshall syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-27" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-08-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10486316</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17236192</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25240749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5653" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2730" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, myopia, cataract, saddle nose-Marshall type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Marshall syndrome</ElementValue>
                <XRef ID="Marshall+syndrome/4487" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007949" DB="MONDO" />
                <XRef ID="33410002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRSHS</ElementValue>
                <XRef Type="MIM" ID="154780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL11A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6984" />
                <XRef ID="6984" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="560" DB="Orphanet" />
              <XRef ID="C0265235" DB="MedGen" />
              <XRef ID="MONDO:0007949" DB="MONDO" />
              <XRef Type="MIM" ID="154780" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6448" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5152" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fibrochondrogenesis 1</ElementValue>
                <XRef ID="3518" DB="GeneTests" />
                <XRef ID="MONDO:0009226" DB="MONDO" />
                <XRef Type="MIM" ID="228520" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FBCG1</ElementValue>
                <XRef ID="GTR000560298" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="228520" DB="OMIM" />
              </Symbol>
              <XRef ID="2021" DB="Orphanet" />
              <XRef ID="C3278138" DB="MedGen" />
              <XRef ID="MONDO:0009226" DB="MONDO" />
              <XRef Type="MIM" ID="228520" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38957" SubmissionDate="2019-08-12" DateLastUpdated="2019-08-14" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120280.0006_MARSHALL SYNDROME" title="COL11A1, 1-BP INS, 3816T_MARSHALL SYNDROME" />
        <ClinVarAccession Accession="SCV000038957" DateUpdated="2019-08-14" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 28-year-old female clinically diagnosed with Marshall syndrome (MRSHS; 154780), Annunen et al. (1999) identified heterozygosity for a 1-bp insertion at the splice donor site of intron 50 of the COL11A1 gene (IVS50DS+3insT). Neither parent had the insertion.</Attribute>
              <Citation>
                <ID Source="PubMed">10486316</ID>
              </Citation>
              <XRef DB="OMIM" ID="154780" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 36-year-old female diagnosed with MRSHS, Majava et al. (2007) identified heterozygosity for the 1-bp insertion in IVS50 of the COL11A1 gene. The patient had severe midface hypoplasia with a short nose, anteverted nares, and bulging eyes; she also had sensorineural hearing loss, but no signs of ectodermal dysplasia. Type I vitreous anomaly was diagnosed in this patient by an experienced ophthalmologist, suggesting that vitreous phenotype does not always allow prediction of the defective gene in Stickler and Marshall syndrome cases.</Attribute>
              <Citation>
                <ID Source="PubMed">17236192</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL11A1" />
          </GeneList>
          <Name>COL11A1, 1-BP INS, 3816T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 3816T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120280.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MARSHALL SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7536635" SubmissionDate="2023-08-23" DateLastUpdated="2023-08-26" DateCreated="2023-08-26">
        <ClinVarSubmissionID localKey="GDXSV:285348" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV004028372" DateUpdated="2023-08-26" DateCreated="2023-08-26" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Intronic splice site variant in a gene for which loss of function is a known mechanism of disease, and splice predictors support a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34680973, 1683158, 25240749, 17236192, 10486316)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL11A1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="1" alternateAllele="A" referenceAllele="-" start="103381184" stop="103381185" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2709131</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_213_20230823054202</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3003195" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_001854.3:c.3816+2dupT|OMIM:228520" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001527980" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10486316</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25240749</ID>
          </Citation>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported arising de novo in two independent patiets with Stickler syndrome [PMID 10486316, 25240749].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL11A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001854.3:c.3816+2dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="228520" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4175464" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4817877|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002151584" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10486316</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25240749</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Comment>This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change falls in intron 50 of the COL11A1 gene. It does not directly change the encoded amino acid sequence of the COL11A1 protein. It affects a nucleotide within the consensus splice site. This variant has been observed in individual(s) with clinical features of autosomal dominant COL11A1-related conditions (PMID: 10486316, 25240749; Invitae). In at least one individual the variant was observed to be de novo. This variant is also known as InsT+3 IVS50. ClinVar contains an entry for this variant (Variation ID: 1032776). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL11A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.103381184_103381185insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38957" TraitType="Disease" MappingType="Name" MappingValue="MARSHALL SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265235" Name="Marshall syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3003195" TraitType="Disease" MappingType="XRef" MappingValue="228520" MappingRef="OMIM">
        <MedGen CUI="C3278138" Name="Fibrochondrogenesis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4175464" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7536635" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

